Designing DNA nanostar hydrogels with programmable degradation and antibody release
Giorgia Palombo, Christine A. Merrick, Jennifer Harnett, Susan Rosser, Davide Michieletto, Yair Augusto Gutiérrez Fosado
TL;DR
The paper addresses the lack of understanding of how DNAns hydrogel design controls degradation and cargo release in vivo. It designs four three-armed DNAns (A–D) with varied arm length, junction flexibility, and linker connectivity, and probes their degradation under site-specific restriction enzymes versus non-specific DNaseI using gel electrophoresis, time-resolved microrheology, and cargo-release assays. Key findings show that linker-free gels resist site-specific cleavage, while relocating recognition sites to linkers enables programmable degradation; initial viscoelasticity is encoded by architecture, and cargo release (including antibodies) can be selectively triggered by enzymes such as EcoRV, enabling targeted delivery while preserving nuclease resistance to unintended nucleases. Together these results establish concrete design rules for DNAns-based hydrogels with tunable degradation and cargo release, advancing DNA-based scaffolds for tissue regeneration, 3D cell culture, and controlled antibody/drug delivery.
Abstract
DNA nanostar (DNAns) hydrogels are promising materials for in vivo applications, including tissue regeneration and drug and antibody delivery. However, a systematic and quantitative understanding of the design principles controlling their degradation is lacking. Here, we investigate hydrogels made of three-armed DNAns with varying flexible joints, arm lengths, and mesh sizes and use restriction enzymes to cut the DNAns structures while monitoring the gel's degradation. We discover that (i) removing flexible joints, (ii) increasing arm length, or (iii) relocating the RE site along a DNA linker markedly accelerates hydrogel degradation. In contrast, non-specific endonucleases, e.g. DNaseI, quicly degrade DNAns hydrogels regardless of design. Importantly, the release of antibodies from DNAns hydrogels can be modulated by the action of different enzymes, confirming that programmable degradation can be leveraged for responsive drug-delivery systems. These findings provide a better understanding of the design principles for DNAns-based scaffolds with tunable degradation, cargo release, and responsive rheology.
